dc.date.accessioned2019-07-04T16:59:24Z
dc.date.available2019-07-04T16:59:24Z
dc.date.created2019-07-04T16:59:24Z
dc.date.issued2019
dc.identifierhttps://hdl.handle.net/20.500.12866/6742
dc.identifierhttps://doi.org/10.1186/s12888-019-2057-z
dc.description.abstractBACKGROUND: Clinical Practice Guidelines (CPGs) should follow an adequate methodology using an evidence-based approach in order to provide reliable recommendations. However, little is known regarding the quality of CPGs for Depression, which precludes its adequate use by stakeholders and mental health professionals. Thus, the aim of this study was to conduct a scoping review to describe the characteristics and quality of CPGs for Depression in adults. METHODS: We searched CPGs for Depression in adults in eighteen databases. We included those that were published in English or Spanish between January 2014 and May 2018 and were based on systematic reviews of the evidence. Two independent authors extracted the characteristics, type and number of recommendations, and quality (using the Appraisal of Guidelines for Research and Evaluation-II [AGREE-II]) of each included CPG. RESULTS: We included eleven CPGs, of which 9/11 did not include the participation of patients in the development of the CPG, 4/11 CPGs had a score >/= 70% in the overall evaluation of AGREE-II, and 3/11 CPGs had a score >/= 70% in its third domain (rigor of development). In addition, only 5/11 CPGs shared their search strategy, while only 4/11 listed the selected studies they used to reach recommendations, and 7/11 CPGs did not clearly state which methodology they used to translate evidence into a recommendation. CONCLUSIONS: Most of evaluated CPGs did not take into account the patient's viewpoints, achieved a low score in the rigor of development domain, and did not clearly state the process used to reach the recommendations. Stakeholders, CPCGs developers, and CPGs users should take this into account when choosing CPGs, and interpreting and putting into practice their issued recommendations.
dc.languageeng
dc.publisherBioMed Central
dc.relationBMC Psychiatry
dc.relation1471-244X
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectpatient participation
dc.subjecthuman
dc.subjectadult
dc.subjectpractice guideline
dc.subjecthealth care quality
dc.subjectdepression
dc.subjectMajor depression
dc.subjectclinical evaluation
dc.subjectReview
dc.subjectclinical feature
dc.subjectclinical practice
dc.subjectacupuncture
dc.subjectsystematic review (topic)
dc.subjectheparin induced thrombocytopenia
dc.subjectAGREE-II
dc.subjectClinical practice guidelines
dc.subjectQuality
dc.subjectfertility preservation
dc.subjectkidney transplantation
dc.subjectmouth cancer
dc.subjectpediatric traumatic brain injury
dc.titleCharacteristics and quality of clinical practice guidelines for depression in adults: A scoping review
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución